SI-BONE, Inc.
16
3
6
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
2 terminated/withdrawn out of 16 trials
75.0%
-11.5% vs industry average
13%
2 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes
Role: lead
Innovative Spinopelvic Solutions With Real-World Evidence
Role: lead
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Role: lead
Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis
Role: collaborator
Complex Adult Deformity Surgery (CADS)
Role: collaborator
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
Role: lead
Pelvic Fixation and Fusion During Multilevel Spinal Surgery
Role: lead
Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants
Role: lead
SI Joint Stabilization in Long Fusion to the Pelvis
Role: lead
Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.
Role: collaborator
Sacral Fracture Fusion/Fixation for Rapid Rehabilitation
Role: lead
Validity and Reliability of Diagnostic Findings of SI Joint Blocking
Role: lead
LOIS: Long-Term Follow-Up in INSITE/SIFI
Role: lead
iFuse Implant System® Minimally Invasive Arthrodesis
Role: lead
Investigation of Sacroiliac Fusion Treatment (INSITE)
Role: lead
Sacroiliac Joint Fusion With iFuse Implant System (SIFI)
Role: lead
All 16 trials loaded